• Welcome
  • Programme
    • Scientific Committee
    • Abstract Submission
    • Accreditation
  • Registration
  • Sponsors & Exhibitors
    • Symposia
  • Venue
    • Suggested Hotels
    • How to get there
    • COVID-19 measures
  • Contact
ICC 2021 - International CTEPH Conference 2021ICC 2021 - International CTEPH Conference 2021
  • Welcome
  • Programme
    • Scientific Committee
    • Abstract Submission
    • Accreditation
  • Registration
  • Sponsors & Exhibitors
    • Symposia
  • Venue
    • Suggested Hotels
    • How to get there
    • COVID-19 measures
  • Contact

Programme

Download Programme
Friday, 10 December 2021
08:15-09:00Registration
09:00-09:10 Welcome and introductionE. Mayer
09:10-09:35Developing concept and definition of CTEPHG. Simonneau
Plenary 1: Pathophysiology, epidemiology (Chairs: M. Delcroix and G. Simonneau)
09:35-10:00Early diagnosis of CTEPH after acute PE in the pre- and post-COVID eraE. Klok
10:00-10:25What have we learned from GWAS?M. Toshner
10:25-10:50The role of the bronchial circulation and microvasculopathyE. Fadel
10:50-11:20Coffee break and poster viewing
Plenary 2: Diagnosis and imaging (Chairs: J. Pepke-Zaba and E. Fadel)
11:20-11:45Mechanisms of cardiac dysfunction in CTEPHA. Vonk Noordegraaf
11:45-12:10Beyond V/Q scan: cutting edge imaging modalitiesN. Screaton
12:10-12:35How to select treatment modalities? – PEA vs BPA?E. Mayer
12:35-14:15Lunch break and poster viewing
Plenary 3: Pulmonary endarterectomy (Chairs: E. Mayer and N. Kim)
14:15-14:40Segmental/subsegmental endarterectomyM. Madani
14:40-15:05Management of peri-operative complicationsD. Jenkins
15:05-15:35Coffee break and poster viewing
Plenary 4: Balloon pulmonary angioplasty (Chairs: H. Matsubara and I. Lang)
15:35-16:00State of the art techniques and complication managementH. Matsubara
16:00-16:25BPA learning curve: the French experienceP. Brenot
16:25-16:50International BPA registryN. Kim
16:50-17:05Poster award and end-of-day conclusionJ. Pepke-Zaba
Saturday, 11 December 2021
Plenary 5: Medical and multimodal therapy (Chairs: D. Jenkins, M. Delcroix)
09:30-10:15Registration
10:15-10:35Role of medical therapy in CTEPHA. Ghofrani
10:35-10:55Medical vs BPA in non-operable patientsX. Jaïs
10:55-11:15Multimodal interventionsC. Wiedenroth
11:15-11:30Panel discussion: multimodal therapy strategies
D. Jenkins,
M. Delcroix, A. Ghofrani, X. Jaïs and C. Wiedenroth
11:30-13:10Lunch break and poster viewing
Plenary 6: Hot topics (Chairs: M. Madani, I. Lang)
13:10-13:25New insights into CTEPH pathogenesis: the role of
neutrophil extracellular traps
I. Lang
13:25-13:40Anticoagulant options in CTEPHM. Hoeper
13:40-13:55CTED without PH: exercise haemodynamics and treatmentS. Guth
13:55-14:10Pulmonary artery denervation after PEAA. Chernyavskiy
14:10-14:20Closing remarksN. Kim
Virtual on-demand contributions
Simulation-based CTEPH trainingO. Mercier
IMPACT programme – destination 2024M. Humbert
PEA: perioperative managementG. Martinez
Intensive care challenges post PEAK. Salaunkey
Case-based approach to the radiological diagnosis of CTEPHM. McInnis

Host

International CTEPH Association
c/o artax Fide Consult AG
Gartenstrasse 95
4002 Basel
Switzerland
Phone: + 41 41 379 79 70
Email: info@cteph-association.org
Web: www.cteph-association.org

Venue

Hotel Dolce
by Wyndham Bad Nauheim
Elvis-Presley-Platz 1 (GPS: Terrassenstrasse)
61231 Bad Nauheim
Germany
Phone: +49 6032 303-0
Email: info@dolcebadnauheim.com
Web: www.dolcebadnauheim.com

Congress Organisation

wikonect GmbH
ICC 2021
Hagenauer Strasse 53
65203 Wiesbaden
Germany
Phone: +49 611 204809-0
Email: icc2021@wikonect.de
Web: www.wikonect.de

 

 

  • Legal Notice
  • Data Privacy Policy
    • Cookie policy (EU)
Manage Cookie Consent
We use cookies to optimise our website and our service. Please choose which ones to accept.
Functional cookies Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}